Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

News & Analysis

China biotech company and industry news and analysis...

Legend Bio to Launch CAR-T in Europe for Multiple Myeloma

Full-Life Closes $37 Million Series A for Radiopharmaceutical Oncology Products

Laekna Starts China-US Trials of AKT Kinase Inhibitor for Breast Cancer

Junshi’s Novel SARS-CoV-2 Therapy Out-Performs Pfizer’s Paxlovid

DongCheng Acquires Imaging Tracer to Predict Immunotherapy Efficacy

ChinaBio Event
Beijing and Digital
September 13-16, 2022
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
July 27-31, 2022